<div class="headline"></div>
    <h2 class="sub_headline">Optistavin was evaluated for safety and tolerability in over 2,700 patients across 3 clinical trials.<sup>1</sup></h2>
<div id="container">
  <div class="section">

    <div class="graph">
	    <div class="header">
	    </div>
	    <div class="body"></div>
	    <div id="controls">
		    <div class="up" onclick="void(0)"></div>
	    </div>
    </div>
  </div>

  <div class="section" id="safety">
    <div class="graph"></div>
    <p class="graph_footer">National Cancer Institute Common Toxicity Criteria grade 3-5 (nonhematologic) and grade 4-5 (hematologic) events.</p>
  </div>

  <div class="section" id="nsclc_safety">
    <div class="graph">
	    <div class="header"></div>
	    <div class="body"></div>
	    <div id="controls">
		    <div class="up" onclick="void(0)"></div>
	    </div> 
		  
    </div>
    <p class="graph_footer footnote"><sup>*</sup>Including fatal outcome. <sup>b</sup>Including intestinal perforation. <sup>c</sup>Underlying etiology not established.</p>
  </div>
  
  <div class="section" id="nsclc_safety_two">
    <div class="graph">
     <div class="header"></div>
     <div class="body"></div>
      <div id="controls">
		    <div class="up" onclick="void(0)"></div>
	    </div>
    </div>
    <p class="graph_footer">National Cancer Institute Common Toxicity Criteria grade 3-5 (nonhematologic) and grade 4-5 (hematologic) events.</p>
  </div>

</div>
<script>
  isa.unlock_scroll();
  isa.show_controls_efficacy(true);
</script>

